Glass Jacobson Investment Advisors’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13K Hold
83
﹤0.01% 442
2026
Q1
$12.7K Hold
83
﹤0.01% 448
2025
Q4
$11.4K Hold
83
﹤0.01% 439
2025
Q3
$10.6K Hold
83
﹤0.01% 445
2025
Q2
$10K Sell
83
-69
-45% -$7.78K ﹤0.01% 426
2025
Q1
$14.8K Hold
152
﹤0.01% 560
2024
Q4
$14.8K Buy
152
+18
+13% +$1.92K ﹤0.01% 560
2024
Q3
$15.4K Hold
134
0.01% 526
2024
Q2
$14.3K Hold
134
0.01% 522
2024
Q1
$13K Hold
134
﹤0.01% 527
2023
Q4
$13.5K Buy
134
+83
+163% +$8.01K 0.01% 491
2023
Q3
$5.2K Hold
51
﹤0.01% 564
2023
Q2
$5.15K Buy
+51
New +$5.1K ﹤0.01% 577
2022
Q4
$4.63K Buy
+51
New +$4.3K ﹤0.01% 601

Other funds holding NVS

Glass Jacobson Investment Advisors's NVS Position: Q2 2026 in Review

Glass Jacobson Investment Advisors held its Novartis (NVS) position steady in Q2 2026 at 83 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #442.

Glass Jacobson Investment Advisors first reported a position in NVS in Q4 2022 and has held it in 14 quarters since. The position peaked at $15.4K in Q3 2024. 1,179 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Glass Jacobson Investment Advisors held 83 shares of Novartis worth $13K as of Q2 2026.
  • Glass Jacobson Investment Advisors left its Novartis share count unchanged in Q2 2026.
  • Novartis made up ﹤0.01% of Glass Jacobson Investment Advisors's portfolio in Q2 2026, its #442 holding.
  • Glass Jacobson Investment Advisors first reported a position in Novartis in Q4 2022 and has held it in 14 quarters since.
  • Glass Jacobson Investment Advisors's Novartis position peaked at $15.4K in Q3 2024.
  • 1,179 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Glass Jacobson Investment Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.